John R. Geiser, Ph.D.

Curriculum vitae

EDUCATION:

Ph.D. in Biochemistry, University of Washington, Seattle, Washington, December 1993.
B.S. in Microbiology - Cum Laude, University of Pittsburgh, Pittsburgh, PA, April 1986.

HONORS:

Post-doctoral Research Fellowship, The Cancer Research Fund of the Damon Runyon-Walter Winchell Foundation, May 1994 - April 1997.

Molecular and Cellular Biology Training Grant, National Institute of General Medical Sciences, January 1992 - May 1993.

Molecular Training Program in Cancer Research, National Cancer Institute, May 1990 - December 1991.

University of Pittsburgh Academic Scholarship, University of Pittsburgh, September 1982 - April 1986.

Top

RESEARCH POSITIONS:

Associate Professor August 2005 - present
Department of Biological Sciences, Western Michigan University, Kalamazoo, Michigan

Assistant Professor August 1999 - July 2005
Department of Biological Sciences, Western Michigan University, Kalamazoo, Michigan

Board of Scientific Advisors November 2003 – present
AureoGen Biosciences, Inc., Biosciences Research and Commercialization Center, Southwest Michigan Innovation Center, Kalamazoo, Michigan

Consultant November 2003 – present
AureoGen Biosciences, Inc., Biosciences Research and Commercialization Center, Southwest Michigan Innovation Center, Kalamazoo, Michigan

Participating Faculty Member/Consultant August 2002 –December 2003
Enlist, Empower and Equip Grant awarded to Dave Rudge, PI under the NSF Science, Technology, Engineering and Mathematics Teacher Preparation (STEMTP) Grant
Department of Biological Sciences, Western Michigan University, Kalamazoo, Michigan

Post-doctoral Research Fellow February 1994 – July 1999
Department of Biology, The Johns Hopkins University, Baltimore, Maryland

Graduate Research Assistant October 1988 - December 1993
Department of Biochemistry, University of Washington, Seattle, Washington

Research Assistant April 1986 - August 1988
Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania

Undergraduate Research Assistant January 1985 - April 1986
Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania

Top

CURRENT SUPPORT:

Michigan Technology Tri-Corridor Fund (2004), November 2004 – October 2007
Generation of novel drugs through genetic engineering of cyclic peptide producing organisms, in collaboration with AureoGen Biosciences, Inc., Ake Elhammer, PI, Jerry Slightom, Co-investigator, John Geiser, Co-investigator/Collaborator, $1,994,476.

Top

PUBLICATIONS:

Geiser, J. R. (2005). Recombinational cloning vectors for regulated expression in Saccharomyces cerevisiae. BioTechniques, 38:378-382.

Nejedlik, L., T. Pierfelice and J. R. Geiser (2004). Actin Distribution is Disrupted upon Expression of Yersinia YopO/YpkA in Yeast. Yeast, 21(9): 759-768.

Geiser, J. R. (2004). Model organism: Saccharomyces cerevisiae (yeast). Published in the Encyclopedia of Genetics, Revised Edition, by Salem Press, Inc.

Sheeman, B., P, Carvalho, I, Sagot, J.R. Geiser, D. Kho, M.A. Hoyt, and D. Pellman (2003). Determinants of S. cerevisiae Dynein Localization and Activation. Implications for the Mechanism of Spindle Positioning. Current Biology, 13(5): 364-372.

Kahana, J. A., G. Schlenstedt, D. M. Evanchuk, J. R. Geiser, M. A. Hoyt and P. A. Silver (1998). The yeast dynactin complex is involved in partitioning the mitotic spindle between mother and daughter cells during anaphase B. Molecular Biology of the Cell, 9(7), 1741-1756.

Geiser, J. R., E. S. Schott, T. J. Kingsbury, N. B. Cole, L. J. Totis, G. Bhattacharyya, L. He, and M. A. Hoyt (1997). Saccharomyces cerevisiae genes required in the absence of the CIN8-encoded spindle motor act in functionally diverse mitotic pathways. Molecular Biology of the Cell, 8(6), 1035-1050.

Hoyt, M. A., J. P. Macke, B. T. Roberts, and J. R. Geiser (1997). Saccharomyces cerevisiae PAC2 functions with CIN1, 2 and 4 in a pathway leading to normal microtubule stability. Genetics, 146(3), 849-857.

Hoyt, M. A. and J. R. Geiser (1996). Genetic analysis of the mitotic spindle. Annual Review of Genetics 30, 7-33.

Moser, M. J., J. R. Geiser and T. N. Davis (1996). Ca2+-calmodulin promotes survival of pheromone-induced growth arrest by activation of calcineurin and Ca2+-calmodulin-dependent protein kinase. Molecular and Cellular Biology 16(9), 4824-4831.

Geiser, J. R., H. A. Sundberg, B. H. Chang, E. G. D. Muller, and T. N. Davis (1993). The essential mitotic target of calmodulin is the 110 kD component of the spindle pole body in Saccharomyces cerevisiae. Molecular and Cellular Biology 13(12), 7913-7924.

Geiser, J. R., D. van Tuinen, S. E. Brockerhoff, M. M. Neff, and T. N. Davis (1991). Can calmodulin function without binding calcium? Cell 65(6), 949-959.

Pogue-Geile, K., J. R. Geiser, M. Shu, C. Miller, I. G. Wool, A. I. Meisler and J. M. Pipas (1991). Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein. Molecular and Cellular Biology 11(8), 3842-3849.

Finley, G. G., N. T. Schulz, S. A. Hill, J. R. Geiser, J. M. Pipas, and A. I. Meisler (1989). Expression of the myc gene family in different stages of human colorectal cancer. Oncogene 4(8), 963-971.

Top

MEETING ABSTRACTS:

Back to Geiser home

Back to BIOS